Market Overview:
The global diagnostic specialty antibody market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of infectious diseases, rising demand for early diagnosis and treatment, and technological advancements in diagnostics. The global diagnostic specialty antibody market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into monoclonal antibodies (MAbs), polyclonal antibodies (PCAs), and recombinant polyclonal antibodies (RPAs). MAbs are further classified into humanized MAbs and chimeric MAbs. PCAs are further classified into rabbit anti-human IgG PCA and goat anti-human IgG PCA. RPAs are further classified into humanized RPAs and non-humanized RPAs.
Product Definition:
A diagnostic specialty antibody is an antibody that is used for the diagnosis of a particular disease or condition. These antibodies can be used to detect and identify proteins or other markers that are associated with a particular disease. This information can help physicians to diagnose the disease and determine the best course of treatment.
Monoclonal Antibodies:
Monoclonal antibodies are antibody molecules, which are manufactured by the human body specifically for a particular disease. They work in opposition to the disease and help fight against it. The normal immune system generally creates an antibody that is specific to a particular protein or antigen on the basis of which an illness is diagnosed. However, sometimes this process takes longer than usual and when there are several possible antigens or proteins involved in an illness then it can take much longer as well.
Polyclonal Antibodies:
Polyclonal antibodies are made by B cells and are used in the detection of specific antigens. They have several advantages over monoclonal antibodies such as they can be produced on a large scale, they do not require constant maintenance, and their use does not require skilled professionals. Polyclonal antibodies can also be used for the detection of food additives or drugs that have been injected into the patient's body.
Application Insights:
The application segment is sub-divided into hepatitis diagnosis, tuberculosis diagnostics, dengue diagnosis, oncology diagnostics, HIV diagnostics and infectious disease diagnostics. Hepatitis diagnosis dominated the global diagnostic specialty antibody market in 2017 owing to a rise in prevalence of chronic hepatitis. According to WHO estimates published in 2018, an estimated 75 million people were diagnosed with chronic hepatitis globally while around 90% of them were found to be attributable due to alcohol consumption or drug abuse. This has resulted in high demand for accurate and rapid diagnostic solutions for hepatic diseases which is anticipated to fuel growth during the forecast period.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of players, high investment in R&D, and increasing prevalence of infectious diseases such as dengue, Zika virus disease, West Nile Virus (WNV), and others. In addition to this, favorable reimbursement policies for advanced diagnostic techniques are also expected to drive growth during the forecast period. Asia Pacific is expected to grow at a lucrative rate over the forecast period owing to rising healthcare expenditure by governments along with private organizations and increasing demand for improved healthcare services resulting from population growth and urbanization.
Growth Factors:
- Increasing incidence of infectious diseases: The increasing incidence of infectious diseases is one of the major growth drivers for the diagnostic specialty antibody market. Infectious diseases are caused by pathogens such as bacteria, viruses, and parasites. These pathogens can cause a wide range of infections that can affect any part of the body. The increasing incidence of infectious diseases is due to several factors such as globalization, changes in lifestyle and eating habits, and increased travel.
- Rising demand for personalized medicine: The rising demand for personalized medicine is another major growth driver for the diagnostic specialty antibody market. Personalized medicine refers to the customization of medical treatment based on an individual’s genetic makeup or health status. This approach helps to ensure that patients receive treatments that are most likely to be effective for them and minimize adverse effects associated with treatment regimens.
Scope Of The Report
Report Attributes
Report Details
Report Title
Diagnostic Specialty Antibody Market Research Report
By Type
Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Polyclonal Antibodies
By Application
Hepatitis Diagnosis, Tuberculosis Diagnostics, Dengue Diagnostics, Oncology Diagnostics, HIV Diagnostics, Infectious Disease Diagnostics, Others Diagnostics
By Companies
Bio-Rad Laboratories, Boehringer Ingelheim International, Agilent Technologies, Abcam, Aytu BioScience
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
238
Number of Tables & Figures
167
Customization Available
Yes, the report can be customized as per your need.
Global Diagnostic Specialty Antibody Market Report Segments:
The global Diagnostic Specialty Antibody market is segmented on the basis of:
Types
Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Polyclonal Antibodies
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hepatitis Diagnosis, Tuberculosis Diagnostics, Dengue Diagnostics, Oncology Diagnostics, HIV Diagnostics, Infectious Disease Diagnostics, Others Diagnostics
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bio-Rad Laboratories
- Boehringer Ingelheim International
- Agilent Technologies
- Abcam
- Aytu BioScience
Highlights of The Diagnostic Specialty Antibody Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Monoclonal Antibodies
- Polyclonal Antibodies
- Recombinant Polyclonal Antibodies
- By Application:
- Hepatitis Diagnosis
- Tuberculosis Diagnostics
- Dengue Diagnostics
- Oncology Diagnostics
- HIV Diagnostics
- Infectious Disease Diagnostics
- Others Diagnostics
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Diagnostic Specialty Antibody Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A diagnostic specialty antibody is a type of antibody that is used to diagnose a specific disease.
Some of the major players in the diagnostic specialty antibody market are Bio-Rad Laboratories, Boehringer Ingelheim International, Agilent Technologies, Abcam, Aytu BioScience.
The diagnostic specialty antibody market is expected to register a CAGR of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Diagnostic Specialty Antibody Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Diagnostic Specialty Antibody Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Diagnostic Specialty Antibody Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Diagnostic Specialty Antibody Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Diagnostic Specialty Antibody Market Size & Forecast, 2018-2028
4.5.1 Diagnostic Specialty Antibody Market Size and Y-o-Y Growth
4.5.2 Diagnostic Specialty Antibody Market Absolute $ Opportunity
Chapter 5 Global Diagnostic Specialty Antibody Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Diagnostic Specialty Antibody Market Size Forecast by Type
5.2.1 Monoclonal Antibodies
5.2.2 Polyclonal Antibodies
5.2.3 Recombinant Polyclonal Antibodies
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Diagnostic Specialty Antibody Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Diagnostic Specialty Antibody Market Size Forecast by Applications
6.2.1 Hepatitis Diagnosis
6.2.2 Tuberculosis Diagnostics
6.2.3 Dengue Diagnostics
6.2.4 Oncology Diagnostics
6.2.5 HIV Diagnostics
6.2.6 Infectious Disease Diagnostics
6.2.7 Others Diagnostics
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Diagnostic Specialty Antibody Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Diagnostic Specialty Antibody Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Diagnostic Specialty Antibody Analysis and Forecast
9.1 Introduction
9.2 North America Diagnostic Specialty Antibody Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Diagnostic Specialty Antibody Market Size Forecast by Type
9.6.1 Monoclonal Antibodies
9.6.2 Polyclonal Antibodies
9.6.3 Recombinant Polyclonal Antibodies
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Diagnostic Specialty Antibody Market Size Forecast by Applications
9.10.1 Hepatitis Diagnosis
9.10.2 Tuberculosis Diagnostics
9.10.3 Dengue Diagnostics
9.10.4 Oncology Diagnostics
9.10.5 HIV Diagnostics
9.10.6 Infectious Disease Diagnostics
9.10.7 Others Diagnostics
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Diagnostic Specialty Antibody Analysis and Forecast
10.1 Introduction
10.2 Europe Diagnostic Specialty Antibody Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Diagnostic Specialty Antibody Market Size Forecast by Type
10.6.1 Monoclonal Antibodies
10.6.2 Polyclonal Antibodies
10.6.3 Recombinant Polyclonal Antibodies
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Diagnostic Specialty Antibody Market Size Forecast by Applications
10.10.1 Hepatitis Diagnosis
10.10.2 Tuberculosis Diagnostics
10.10.3 Dengue Diagnostics
10.10.4 Oncology Diagnostics
10.10.5 HIV Diagnostics
10.10.6 Infectious Disease Diagnostics
10.10.7 Others Diagnostics
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Diagnostic Specialty Antibody Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Diagnostic Specialty Antibody Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Diagnostic Specialty Antibody Market Size Forecast by Type
11.6.1 Monoclonal Antibodies
11.6.2 Polyclonal Antibodies
11.6.3 Recombinant Polyclonal Antibodies
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Diagnostic Specialty Antibody Market Size Forecast by Applications
11.10.1 Hepatitis Diagnosis
11.10.2 Tuberculosis Diagnostics
11.10.3 Dengue Diagnostics
11.10.4 Oncology Diagnostics
11.10.5 HIV Diagnostics
11.10.6 Infectious Disease Diagnostics
11.10.7 Others Diagnostics
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Diagnostic Specialty Antibody Analysis and Forecast
12.1 Introduction
12.2 Latin America Diagnostic Specialty Antibody Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Diagnostic Specialty Antibody Market Size Forecast by Type
12.6.1 Monoclonal Antibodies
12.6.2 Polyclonal Antibodies
12.6.3 Recombinant Polyclonal Antibodies
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Diagnostic Specialty Antibody Market Size Forecast by Applications
12.10.1 Hepatitis Diagnosis
12.10.2 Tuberculosis Diagnostics
12.10.3 Dengue Diagnostics
12.10.4 Oncology Diagnostics
12.10.5 HIV Diagnostics
12.10.6 Infectious Disease Diagnostics
12.10.7 Others Diagnostics
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Diagnostic Specialty Antibody Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Diagnostic Specialty Antibody Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Diagnostic Specialty Antibody Market Size Forecast by Type
13.6.1 Monoclonal Antibodies
13.6.2 Polyclonal Antibodies
13.6.3 Recombinant Polyclonal Antibodies
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Diagnostic Specialty Antibody Market Size Forecast by Applications
13.10.1 Hepatitis Diagnosis
13.10.2 Tuberculosis Diagnostics
13.10.3 Dengue Diagnostics
13.10.4 Oncology Diagnostics
13.10.5 HIV Diagnostics
13.10.6 Infectious Disease Diagnostics
13.10.7 Others Diagnostics
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Diagnostic Specialty Antibody Market: Competitive Dashboard
14.2 Global Diagnostic Specialty Antibody Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bio-Rad Laboratories
14.3.2 Boehringer Ingelheim International
14.3.3 Agilent Technologies
14.3.4 Abcam
14.3.5 Aytu BioScience
